ABSTRACT
PURPOSE: To investigate the effect of vardenafil in kidney of rats submitted to acute ischemia and reperfusion. METHODS: Twenty-eight rats were randomly distributed into two groups. Right nephrectomy was performed and the vardenafil group received vardenafil solution (at a concentration of 1 mg/ml in 10 mg/kg) while the control group received 0.9% saline solution (SS) one hour prior to the ligature of the left renal pedicle. After one hour of ischemia, animals were submitted to twenty-four hours of reperfusion, followed by left nephrectomy. The kidney's histological parameters evaluated on the study included vacuolar degeneration and tubular necrosis. Apoptosis was assessed by immunohistochemistry for cleaved caspase-3 using the point-counting and digital methods (Cytophotometry). Also, a biochemical analysis for creatinine was conducted. RESULTS: There were statistically significant differences between groups only with regards to the vacuolar degeneration parameter and to the cleaved caspase-3 digital method. CONCLUSION: Vardenafil showed a protective effect on the kidney of rats subjected to acute ischemia and reperfusion in this model .
Subject(s)
Animals , Male , Imidazoles/therapeutic use , Ischemia/prevention & control , Kidney/blood supply , Kidney/drug effects , /therapeutic use , Piperazines/therapeutic use , Reperfusion Injury/prevention & control , Apoptosis/drug effects , /analysis , Disease Models, Animal , Immunohistochemistry , Kidney/pathology , Random Allocation , Rats, Wistar , Reproducibility of Results , Sulfones/therapeutic use , Time Factors , Treatment Outcome , Triazines/therapeutic use , Vardenafil DihydrochlorideABSTRACT
PURPOSE: To investigate whether cilostazol has a protective effect on acute ischemia and reperfusion of hind limbs of rats through study of biochemical variables in blood and urine. METHODS: Forty six animals were randomized and divided into two groups. Group I received a solution of cilostazol (10 mg/Kg) and group II received saline solution 0.9% (SS) by orogastric tube after ligature of the abdominal aorta. After four hours of ischemia the animals were divided into four subgroups: group IA (Cilostazol): two hours of reperfusion. Group IIA (SS): two hours of reperfusion. Group IB (Cilostazol): six hours of reperfusion. Group IIB (SS) six hours of reperfusion. After the reperfusion period, was held to collect urine and blood for biochemical measurements. The biochemical parameters studied were: urea, creatinine, sodium, potassium and myoglobin in blood and urea, creatinine, myoglobin in urine. RESULTS: There was no statistically significant difference between groups. CONCLUSION: Cilostazol had no protective effect on ischemic acute reperfusion of hind limbs of rats in this model.
Subject(s)
Animals , Male , Rats , Hindlimb/blood supply , Platelet Aggregation Inhibitors/pharmacology , Reperfusion Injury/drug therapy , Tetrazoles/pharmacology , Creatinine/blood , Creatinine/urine , Disease Models, Animal , Myoglobin/blood , Random Allocation , Rats, Wistar , Reproducibility of Results , Time Factors , Urea/blood , Urea/urineABSTRACT
PURPOSE: To investigate the effect of cilostazol, in kidney and skeletal muscle of rats submitted to acute ischemia and reperfusion. METHODS: Fourty three animals were randomized and divided into two groups. Group I received a solution of cilostazol (10 mg/Kg) and group II received saline solution 0.9% (SS) by orogastric tube after ligature of the abdominal aorta. After four hours of ischemia the animals were divided into four subgroups: group IA (Cilostazol): two hours of reperfusion. Group IIA (SS): two hours of reperfusion. Group IB (Cilostazol): six hours of reperfusion. Group IIB (SS) six hours of reperfusion. After reperfusion, a left nephrectomy was performed and removal of the muscles of the hind limb. The histological parameters were studied. In kidney cylinders of myoglobin, vacuolar degeneration and acute tubular necrosis. In muscle interstitial edema, inflammatory infiltrate, hypereosinophilia fiber, cariopicnose and necrosis. Apoptosis was assessed by immunohistochemistry for cleaved caspase-3 and TUNEL. RESULTS: There was no statistically significant difference between groups. CONCLUSION: Cilostazol had no protective effect on the kidney and the skeletal striated muscle in rats submitted to acute ischemia and reperfusion in this model.
OBJETIVO: Investigar o efeito do cilostazol no rim e na musculatura esquelética de ratos submetidos à isquemia aguda e reperfusão. MÉTODOS: Quarenta e três animais foram aleatoriamente distribuídos em dois grupos. Grupo I recebeu solução de cilostazol (10 mg/Kg) e Grupo II recebeu solução fisiológica a 0,9% (SF), após ligadura da aorta abdominal. Decorridas quatro horas de isquemia os animais foram distribuídos em quatro subgrupos: Grupo IA (Cilostazol): duas horas de reperfusão. Grupo IIA (SF): duas horas de reperfusão. Grupo IB (Cilostazol): seis horas de reperfusão. Grupo IIB (SF): seis horas de reperfusão. Após a reperfusão, realizou-se nefrectomia esquerda e a retirada da musculatura de membro posterior. Os parâmetros histológicos estudados em rim foram cilindros de mioglobina, degeneração vacuolar e necrose tubular. Em músculo foram edema, infiltrado inflamatório, hipereosinofilia de fibras, cariopicnose e necrose. A apoptose foi avaliada por imunohistoquímica, através da caspase-3 clivada e TUNEL. RESULTADOS: Não houve diferença estatisticamente significante entre os grupos estudados. CONCLUSÃO: O cilostazol não teve efeito protetor sobre o rim e sobre a musculatura estriada esquelética em ratos Wistar submetidos à isquemia aguda e reperfusão no modelo estudado.
Subject(s)
Animals , Male , Rats , Hindlimb/blood supply , Hindlimb/drug effects , Ischemia/drug therapy , Kidney/drug effects , Muscle, Skeletal/drug effects , Reperfusion Injury/drug therapy , Tetrazoles/pharmacology , Vasodilator Agents/pharmacology , Apoptosis/drug effects , /analysis , Disease Models, Animal , In Situ Nick-End Labeling , Kidney/blood supply , Kidney/pathology , Muscle, Skeletal/blood supply , Random Allocation , Rats, Wistar , Reproducibility of Results , Reperfusion Injury/prevention & control , Time Factors , Treatment Outcome , Tetrazoles/therapeutic use , Vasodilator Agents/therapeutic useABSTRACT
OBJETIVO: Verificar o efeito do tempo de isquemia sobre as alterações oxidativas, a capacidade antioxidante total e o óxido nítrico, no músculo, no rim e no plasma de ratos submetidos à isquemia e reperfusão de membros posteriores. MÉTODOS: 40 ratos machos foram distribuídos aleatóriamente em quatro grupos experimentais com 10 animais cada. Laparotomia, isolamento da aorta abdominal infra e justa renal. Grupos 1 e 3 (simulados) passagem do fio monofilamentar de polipropileno 7-0 ao redor da aorta sem liga-la e espera de 1 hora para o grupo 1 e de 6 horas para o grupo 3. Retirada do fio, espera de 15 minutos, eutanásia e colheita do material. Grupos 2 e 4 (experimentos), ligadura da aorta abdominal com o mesmo fio e isquemia de 1 hora no grupo 2 e de 6 horas no grupo 4. Retirada do fio e reperfusão por 15 minutos. Eutanásia e colheita de sangue por escoamento, músculo da pata posterior esquerda e rim esquerdo. Os parâmetros verificados foram: malondialdeído, capacidade antioxidante total e óxido nítrico. RESULTADOS: Utilizou-se o teste "t"de Student e o teste de MANN-WHITNEY como testes não paramétricos e fixou-se em 0,05 ou 5 por cento o nível de rejeição. Houve alterações estatísticamente significantes do malondialdeído no rim. A capacidade antioxidante total apresentou alterações significantes no rim, no músculo e no plasma enquanto que, o óxido nítrico, alterou apenas no plasma. CONCLUSÃO: A variação do tempo de isquemia provocou alterações significantes do malondialdeído, da capacidade antioxidante total e do óxido nítrico.